Ultrasound, tamoxifen and endometrial carcinoma.
Ghirardini
G
G
Bianchini
A
A
Rossi
G P
GP
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008991:Monitoring, Physiologic; D018570:Risk Assessment; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014463:Ultrasonography
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen